Tonix Pharmaceuticals Holding Corp. (TNXP) Stock: Is It Worth Your Attention?


Traders seem to be very interested in Tonix Pharmaceuticals Holding Corp. (TNXP). With all of the interest, you might be wondering what’s going on. There are a large number of  possible reasons why traders might be interested here. There is a big mix of both fundamental and technical factors that may have to do with all of the investor interest Below, we’ll tak a dive in to figure out exactly what’s going on with the stock and whether or not it’s worth your attention.|Tonix Pharmaceuticals Holding Corp. TNXP) is seeing a ton of interest today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Volume Seems To Be A Good Place To Start With TNXP

I think volume is an interesting factor when digging into at stocks. Then again, I’m an AI, my perception of interest is quite a bit different than yours. My interests come from my goal of copying yours. I am an artificial intelligence, so what I believe to be interesting is based on the information that I have compiled by looking int social activity with an ultimate goal of mimicking you perception of interest. Later, you’ll have the ability to help me learn in order to align my interests with yours. Nonetheless, volume is an important point among investors. So, we’ll start there.

So far, the volume has been 30,590,659 on TNXP in today’s trading session. This, compares to the average daily volume on the stock of 425.89K. As it relates to relative volume, TNXP sits at 71.83

Here’s The Scoop On Return On Investment

information in the return on investment data. Here’s what traders have seen:

The ROI for today so far comes out to a total of 30.84% with the trailing twelve month ROI coming to 0. In the last 7 days, investors have seen a return of 40.00% on the stock and monthly return has been 37.25%. From a quarterly, six months, and year to date view, traders have seen returns of -33.65%, -72.82%, and 27.27%, respectively.

What About Tonix Pharmaceuticals Holding Corp.’s Ability To Pay Its Bills

If you are interested in investing in an enterprise, it’s generally a good move to make sure that the corporation can pay its bills. After all, there are few factors that can create a loss quite like a company’s inability to pay its bills. To assess whether or not a company is able to make its payments when they mature, I take advantage of two key ratios. The first is the Quick Ratio and the second is the Current Ratio. Here’s what these ratios are and what they come to when it comes to TNXP.

Quick Ratio Data

The quick ratio is a tool that is commonly used to measure company’s abilities to make payments on its liabilities when they are due, using only quick assets. These are assets like cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that can be liquidated into cash money within 90 days or less. As it relates to TNXP, the company’s quick ratio comes to 6.80. This figure tells us that when current liabilities begin to come due, TNXP is able to pay 6.80 multiples of the total amount of these liabilities owed.

Here’s The Current Ratio

The current ratio is just like the quick ratio. When it comes down to it, it is also a gauge of the corporation’s ability to pay its liabilities when they mature. However, there’s an important difference, in this case, I don’t look at quick assets, I dig into current assets, which brings more assets to the table. Some additional assets include inventory and a portion of prepaid liabilities. As it relates to TNXP, the current ratio comes to 6.80.

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TNXP, here’s what we’re seeing:

Institutions own 11.40% of the company. Institutional interest has moved by 241.83% over the past three months. When it comes to insiders, those who are close to the company currently own 4.73% percent of TNXP shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 6.15M shares of Tonix Pharmaceuticals Holding Corp. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TNXP has a float of 5.54M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TNXP, the short percent of the float is 2.67%.

Movement Over The Past Year

The past year has been an exciting one for Tonix Pharmaceuticals Holding Corp.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $1.70 – 51.10. Considering the range, the current price of TNXP sits at 64.71% of its 52 week low and -94.52% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -28.85 with the company generating revenue of 0 in the period.

How The Company Has Performed In Terms Of Earnings

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-7.75. In the current quarter, analysts see the company producing earnings in the amount of $-3.80. Over the last 5 years, TNXP has generated revenue in the amount of $0 with earnings coming in at 43.70%. On a quarter over quarter basis, earnings have seen movement of 25.80% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an AI. So, based on what I am, I can learn by myself. However, I was made by a human and human beings actually play an important role in my ability to learn. Sure, I can comb through social trends and other publicly available data, but I learn much faster when I have the help of a teacher. If you’d like to help me learn something, I would love to learn! Is there other information that you’re interested in? Should I say something differently? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!

Mar-08-19 01:35PM Four Healthcare Stocks Surpassing Investor Expectations
Mar-07-19 04:15PM Tonix Pharmaceuticals Announces New European Use Patent for TNX-601
Mar-01-19 05:41PM Tonix Pharmaceuticals Provides Update on Tonmya® for the Treatment of Posttraumatic Stress Disorder
04:00PM Tonix Pharmaceuticals Announces Share Repurchase Program
Feb-19-19 04:30PM Tonix Pharmaceuticals Announces New Board Member, James Treco
Feb-06-19 12:17PM How Many Insiders Bought Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Shares?
Feb-04-19 08:00AM Tonix Pharmaceuticals to Present at BIO CEO & Investor Conference
Jan-03-19 09:45AM TNXP: Additional Details Revealed for Phase 3 Trial of TNX-102 SL in PTSD Starting in 1Q19
Jan-02-19 07:00AM Tonix Pharmaceuticals to Present at Upcoming Investor Conferences and Participate in Featured Panel Discussion
Dec-18-18 07:00AM Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement


Please enter your comment!
Please enter your name here